In a prostate cancer xenograft mouse model, adoptive NK-92MICD64 cell transferred with anti-TROP2 and B12 mAb led to excellent tumor control and maintained long-term survival of tumor-bearing mice [173]. This evidence concerns the gene TACSTD2 and neoplasm.